Cholesterol Ratio Calculator
Estimate your cholesterol ratio with our free metabolic disorders calculator. See reference ranges, risk factors, and next-step guidance.
Formula
TC/HDL Ratio = Total Cholesterol / HDL; LDL/HDL Ratio = LDL / HDL; AIP = log10(TG/HDL)
Where TC/HDL ratio (Castelli Risk Index I) divides total cholesterol by HDL cholesterol, LDL/HDL ratio (Castelli Risk Index II) measures the balance of harmful to protective cholesterol, the Triglyceride/HDL ratio serves as a surrogate marker for insulin resistance, and AIP (Atherogenic Index of Plasma) is the base-10 logarithm of triglycerides divided by HDL, all values in mg/dL.
Worked Examples
Example 1: Favorable Lipid Profile Assessment
Problem: A patient has Total Cholesterol 190 mg/dL, HDL 65 mg/dL, LDL 100 mg/dL, and Triglycerides 120 mg/dL. Calculate all cholesterol ratios.
Solution: TC/HDL Ratio = 190 / 65 = 2.92 (Optimal, below 3.5)\nLDL/HDL Ratio = 100 / 65 = 1.54 (Optimal, below 2.5)\nTriglyceride/HDL Ratio = 120 / 65 = 1.85 (Low insulin resistance)\nNon-HDL Cholesterol = 190 - 65 = 125 mg/dL\nVLDL = 120 / 5 = 24 mg/dL\nAIP = log10(120/65) = log10(1.85) = 0.266
Result: All ratios in optimal or near-optimal range. Low cardiovascular risk profile.
Example 2: High-Risk Lipid Profile with Metabolic Markers
Problem: A patient has Total Cholesterol 260 mg/dL, HDL 35 mg/dL, LDL 170 mg/dL, and Triglycerides 280 mg/dL. Assess cardiovascular risk.
Solution: TC/HDL Ratio = 260 / 35 = 7.43 (Very High Risk)\nLDL/HDL Ratio = 170 / 35 = 4.86 (Very High Risk)\nTriglyceride/HDL Ratio = 280 / 35 = 8.0 (High insulin resistance)\nNon-HDL Cholesterol = 260 - 35 = 225 mg/dL (well above 130 target)\nVLDL = 280 / 5 = 56 mg/dL\nAIP = log10(280/35) = log10(8.0) = 0.903 (Very High Risk)
Result: All ratios indicate very high cardiovascular risk. Immediate lifestyle intervention and likely statin therapy indicated.
Frequently Asked Questions
What is the cholesterol ratio and why is it considered more important than total cholesterol alone?
The cholesterol ratio (total cholesterol divided by HDL cholesterol) provides a more comprehensive assessment of cardiovascular risk than any single cholesterol measurement alone. Total cholesterol includes both protective HDL cholesterol and harmful LDL cholesterol, so a high total cholesterol with very high HDL may actually represent lower risk than moderate total cholesterol with very low HDL. The ratio captures this relationship by measuring the balance between atherogenic (artery-clogging) and anti-atherogenic (artery-protecting) lipoproteins. A ratio below 3.5 is considered optimal, while ratios above 5.0 indicate significantly increased cardiovascular risk. The American Heart Association considers the cholesterol ratio a useful tool for assessing relative risk.
How is LDL cholesterol calculated using the Friedewald equation?
The Friedewald equation estimates LDL cholesterol from other measured lipid values using the formula: LDL = Total Cholesterol - HDL - (Triglycerides / 5), where all values are in mg/dL. In mmol/L units, the divisor changes to 2.2 instead of 5. This equation works because total cholesterol equals the sum of LDL, HDL, and VLDL, and VLDL can be estimated as triglycerides divided by 5. The equation has important limitations: it becomes inaccurate when triglycerides exceed 400 mg/dL because the VLDL estimation breaks down, it underestimates LDL at very low levels, and it is unreliable in non-fasting samples. Direct LDL measurement is available but more expensive. Newer equations like the Martin-Hopkins formula improve accuracy at low LDL levels.
What is non-HDL cholesterol and why do guidelines increasingly emphasize it?
Non-HDL cholesterol is simply total cholesterol minus HDL cholesterol, and it represents all the atherogenic (artery-damaging) lipoproteins in the blood, including LDL, VLDL, IDL, and lipoprotein(a). Unlike LDL cholesterol, non-HDL cholesterol does not require fasting blood samples and is not affected by elevated triglycerides, making it more reliable across diverse clinical scenarios. Current guidelines from the European Society of Cardiology and others have elevated non-HDL cholesterol as a secondary treatment target, with goals of less than 130 mg/dL for moderate-risk patients and less than 100 mg/dL for high-risk patients. Non-HDL cholesterol is approximately 30 mg/dL higher than LDL cholesterol in most individuals and has been shown in meta-analyses to be a better predictor of cardiovascular events than LDL cholesterol alone.
How do different dietary patterns affect cholesterol ratios?
Different dietary approaches affect cholesterol components and their ratios through distinct mechanisms. The Mediterranean diet (rich in olive oil, nuts, fish, and vegetables) typically improves HDL, lowers triglycerides, and reduces the TC/HDL ratio. Low-carbohydrate and ketogenic diets often dramatically reduce triglycerides and improve the triglyceride/HDL ratio but may increase total and LDL cholesterol. Plant-based diets tend to lower total and LDL cholesterol significantly but may also modestly reduce HDL. The DASH diet reduces total and LDL cholesterol while maintaining HDL levels. Replacing saturated fats with unsaturated fats generally improves the LDL/HDL ratio. Adding soluble fiber (oats, beans, barley) reduces LDL without affecting HDL, improving all ratios. The optimal dietary approach depends on which specific lipid abnormality predominates in each individual.
At what cholesterol ratio values should medication be considered?
Treatment decisions should not be based solely on cholesterol ratios but should consider overall cardiovascular risk using validated risk calculators like the ACC/AHA Pooled Cohort Equation or the European SCORE system. However, as general guidelines, a TC/HDL ratio consistently above 5.0, an LDL/HDL ratio above 3.5, or a triglyceride/HDL ratio above 3.5 in the context of other cardiovascular risk factors typically warrants discussion about statin therapy or other lipid-lowering medications. Statins are the first-line treatment for elevated LDL cholesterol and improve cholesterol ratios by lowering LDL 30-50% while modestly raising HDL. For patients with persistent triglyceride elevation, omega-3 fatty acids (icosapent ethyl/Vascepa) or fibrates may be added. Lifestyle modifications should be attempted for at least 3-6 months before initiating medication in patients without established cardiovascular disease.
How accurate are the results from Cholesterol Ratio Calculator?
All calculations use established mathematical formulas and are performed with high-precision arithmetic. Results are accurate to the precision shown. For critical decisions in finance, medicine, or engineering, always verify results with a qualified professional.